Inhibitory effect of acarbose on tyrosinase: application of molecular dynamics integrating inhibition kinetics

References

• Campbell, L. K., White, J. R., & Campbell, R. K. (1996). Acarbose: Its role in the treatment of diabetes mellitus. The Annals of Pharmacotherapy, 30(11), 1255–1262.https://doi.org/10.1177/106002809603001110
   PubMed Web of Science ®Google Scholar
• Cheng, Y., & Prusoff, W. H. (1973). Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochemical Pharmacology. 22, 3099–3108. https://doi.org/10.1016/0006-2952(73)90196-2
   PubMed Web of Science ®Google Scholar
• DiNicolantonio, J. J., Bhutani, J., & O'Keefe, J. H. (2015). Acarbose: Safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes. Open Heart, 2(1), e000327.https://doi.org/10.1136/openhrt-2015-000327
   PubMed Web of Science ®Google Scholar
• Gou, L., Lee, J., Hao, H., Park, Y. D., Zhan, Y., & Lü, Z. R. (2017). The effect of oxaloacetic acid on tyrosinase activity and structure: Integration of inhibition kinetics with docking simulation. International Journal of Biological Macromolecules, 101, 59–66.https://doi.org/10.1016/j.ijbiomac.2017.03.073
   PubMed Web of Science ®Google Scholar
• Gou, L., Lü, Z. R., Park, D., Oh, S. H., Shi, L., Park, S. J., Bhak, J., Park, Y. D., Ren, Z. L., & Zou, F. (2008). The effect of histidine residue modification on tyrosinase activity and conformation: Inhibition kinetics and computational prediction. Journal of Biomolecular Structure and Dynamics. 26, 395–402. https://doi.org/10.1080/07391102.2008.10507254
   PubMed Web of Science ®Google Scholar
• Gu, S., Shi, J., Tang, Z., Sawhney, M., Hu, H., Shi, L., Fonseca, V., & Dong, H. (2015). Comparison of glucose lowering effect of metformin and acarbose in type 2 diabetes mellitus: A meta-analysis. PLoS One. 10, e0126704. https://doi.org/10.1371/journal.pone.0126704
   PubMed Web of Science ®Google Scholar
• Hanefeld, M., & Schaper, F. (2008). Acarbose: Oral anti-diabetes drug with additional cardiovascular benefits. Expert Review of Cardiovascular Therapy, 6(2), 153–163.https://doi.org/10.1586/14779072.6.2.153
   PubMedGoogle Scholar
• Kumari, S., Tien Guan Thng, S., Kumar Verma, N., & Gautam, H. K. (2018). Melanogenesis inhibitors. Acta Dermato-Venereologica, 98(10), 924–931.https://doi.org/10.2340/00015555-3002
   PubMed Web of Science ®Google Scholar
• Le, L., Sirés-Campos, J., Raposo, G., Delevoye, C., & Marks, M. S. (2021). Melanosome biogenesis in the pigmentation of mammalian skin. Integrative and Comparative Biology, 61(4), 1517–1545.https://doi.org/10.1093/icb/icab078
   PubMed Web of Science ®Google Scholar
• Lin, J. Y., & Fisher, D. E. (2007). Melanocyte biology and skin pigmentation. Nature, 445(7130), 843–850.https://doi.org/10.1038/nature05660
   PubMed Web of Science ®Google Scholar
• Liu, X. X., Sun, S. Q., Wang, Y. J., Xu, W., Wang, Y. F., Park, D., Zhou, H. M., & Han, H. Y. (2013). Kinetics and computational docking studies on the inhibition of tyrosinase induced by oxymatrine. Applied Biochemistry and Biotechnology, 169(1), 145–158.https://doi.org/10.1007/s12010-012-9960-9
   PubMed Web of Science ®Google Scholar
• Ramsden, C. A., & Riley, P. A. (2014). Tyrosinase: The four oxidation states of the active site and their relevance to enzymatic activation, oxidation and inactivation. Bioorganic & Medicinal Chemistry, 22(8), 2388–2395.https://doi.org/10.1016/j.bmc.2014.02.048
   PubMed Web of Science ®Google Scholar
• Samulitis, B. K., Goda, T., Lee, S. M., & Koldovský, O. (1987). Inhibitory mechanism of acarbose and 1-deoxynojirimycin derivatives on carbohydrases in rat small intestine. Drugs under Experimental and Clinical Research, 13(8), 517–524.
   PubMedGoogle Scholar
• Si, Y. X., Wang, Z. J., Park, D., Jeong, H. O., Ye, S., Chung, H. Y., Yang, J. M., Yin, S. J., & Qian, G. Y. (2012). Effects of isorhamnetin on tyrosinase: Inhibition kinetics and computational simulation. Bioscience, Biotechnology, and Biochemistry, 76, 1091–1097. https://doi.org/10.1271/bbb.110910
   PubMed Web of Science ®Google Scholar
• Si, Y. X., Yin, S. J., Park, D., Chung, H. Y., Yan, L., Lü, Z. R., Zhou, H. M., Yang, J. M., Qian, G. Y., & Park, Y. D. (2011). Tyrosinase inhibition by isophthalic acid: Kinetics and computational simulation. International Journal of Biological Macromolecules, 48(4), 700–704.https://doi.org/10.1016/j.ijbiomac.2011.02.015
   PubMed Web of Science ®Google Scholar
• Tams, J. W., & Welinder, K. G. (1996). Unfolding and refolding of Coprinus cinereus peroxidase at high pH, in urea, and at high temperature. Effect of organic and ionic additives on these processes. Biochemistry, 35(23), 7573–7579. https://doi.org/10.1021/bi953067l
   PubMed Web of Science ®Google Scholar
• Wang, Z. J., Ma, W., Yang, J. M., Kang, Y., & Park, Y. D. (2018). Effects of Cu2+ on alkaline phosphatase from Macrobrachium rosenbergii. International Journal of Biological Macromolecules, 117, 116–123. https://doi.org/10.1016/j.ijbiomac.2018.05.165
   PubMed Web of Science ®Google Scholar
• Xiong, S. L., Lim, G. T., Yin, S. J., Lee, J., Si, Y. X., Yang, J. M., Park, Y. D., & Qian, G. Y. (2019). The inhibitory effect of pyrogallol on tyrosinase activity and structure: Integration study of inhibition kinetics with molecular dynamics simulation. International Journal of Biological Macromolecules, 121, 463–471.https://doi.org/10.1016/j.ijbiomac.2018.10.046
   PubMed Web of Science ®Google Scholar
• Xu, J. H., Lee, J., Wang, W., & Park, Y. D. (2022). Application of computational simulation integrating inhibition kinetics for detecting tyrosinase inhibitor: Salsalate is a new inhibitor. Protein & Peptide Letters, 29(9), 744–759. https://doi.org/10.2174/0929866529666220805145244
   PubMed Web of Science ®Google Scholar
• Xue, Y. P., Qin, J. W., Wang, Y. J., Wang, Y. S., & Zheng, Y. G. (2013). Enhanced production of acarbose and concurrently reduced formation of impurity c by addition of validamine in fermentation of Actinoplanes utahensis ZJB-08196. BioMed Research International, 2013, 705418.https://doi.org/10.1155/2013/705418
   PubMed Web of Science ®Google Scholar
• Yin, S. J., Si, Y. X., & Qian, G. Y. (2011). Inhibitory effect of phthalic acid on tyrosinase: The mixed-type inhibition and docking simulations. Enzyme Research, 2011, 294724.https://doi.org/10.4061/2011/294724
   PubMedGoogle Scholar
• Yin, S. J., Si, Y. X., Wang, Z. J., Wang, S. F., Oh, S., Lee, S., Sim, S. M., Yang, J. M., Qian, G. Y., Lee, J., & Park, Y. D. (2011). The effect of thiobarbituric acid on tyrosinase: Inhibition kinetics and computational simulation. Journal of Biomolecular Structure and Dynamics. 29, 463–470. https://doi.org/10.1080/07391102.2011.10507398
   PubMed Web of Science ®Google Scholar
• Zolghadri, S., Bahrami, A., Hassan Khan, M. T., Munoz-Munoz, J., Garcia-Molina, F., Garcia-Canovas, F., & Saboury, A. A. (2019). A comprehensive review on tyrosinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 34(1), 279–309.https://doi.org/10.1080/14756366.2018.1545767
   PubMed Web of Science ®Google Scholar